Literature DB >> 15755992

An orthotopic model of anaplastic thyroid carcinoma in athymic nude mice.

Seungwon Kim1, Young-Wook Park, Bradley A Schiff, Dao D Doan, Yasemin Yazici, Samar A Jasser, Maher Younes, Mahitosh Mandal, Benjamin N Bekele, Jeffrey N Myers.   

Abstract

PURPOSE: To develop an orthotopic model of anaplastic thyroid carcinoma (ATC) in athymic nude mice. EXPERIMENTAL
DESIGN: Various thyroid carcinoma cell lines were injected into the thyroid gland of athymic nude mice to determine whether such injection was technically feasible. ATC cells were then injected into the thyroid gland or the subcutis of nude mice at various concentrations, and the mice were then followed for tumor development. The tumors were examined histopathologically for local invasion or regional or distant metastasis.
RESULTS: Injection of tumor cells into the thyroid glands of nude mice was technically feasible and resulted in the formation of thyroid tumors. The ATC cell line DRO showed significantly higher tumorigenicity in the thyroid gland than in the subcutis. In contrast, oral squamous cell carcinoma cell line TU167 shows no significantly higher tumorigenicity in the thyroid gland than in the subcutis. ATC tumors established in the thyroid gland also produced symptomatic compression of the esophagus and the trachea. Local invasion of the larynx and trachea was as well as high rates of pulmonary metastasis were also observed. Immunohistochemical staining showed higher microvessel density as well as higher expression of vascular endothelial growth factor and interleukin-8 in the orthotopic thyroid tumors than in ectopic tumors.
CONCLUSION: An orthotopic model of ATC in athymic nude mice was developed that closely recapitulates the clinical findings of human ATC. This model should facilitate the understanding of the pathogenesis of ATC and aid in the development of novel therapies against ATC.

Entities:  

Mesh:

Year:  2005        PMID: 15755992     DOI: 10.1158/1078-0432.CCR-04-1908

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  29 in total

1.  Nuclear factor κB-dependent regulation of angiogenesis, and metastasis in an in vivo model of thyroid cancer is associated with secreted interleukin-8.

Authors:  Kevin T Bauerle; Rebecca E Schweppe; Gregory Lund; Gregory Kotnis; Gagan Deep; Rajesh Agarwal; Nikita Pozdeyev; William M Wood; Bryan R Haugen
Journal:  J Clin Endocrinol Metab       Date:  2014-04-23       Impact factor: 5.958

2.  Fast, reproducible measurement of the vascular input function in mice using constrained reconstruction and cardiac sampling.

Authors:  Dustin K Ragan; Stephen Y Lai; James A Bankson
Journal:  NMR Biomed       Date:  2010-09-22       Impact factor: 4.044

3.  Sorafenib and Quinacrine Target Anti-Apoptotic Protein MCL1: A Poor Prognostic Marker in Anaplastic Thyroid Cancer (ATC).

Authors:  Junaid Abdulghani; Prashanth Gokare; Jean-Nicolas Gallant; David Dicker; Tiffany Whitcomb; Timothy Cooper; Jiangang Liao; Jonathan Derr; Jing Liu; David Goldenberg; Niklas K Finnberg; Wafik S El-Deiry
Journal:  Clin Cancer Res       Date:  2016-06-15       Impact factor: 12.531

Review 4.  Lessons from mouse models of thyroid cancer.

Authors:  Caroline S Kim; Xuguang Zhu
Journal:  Thyroid       Date:  2009-12       Impact factor: 6.568

5.  A novel orthotopic mouse model of human anaplastic thyroid carcinoma.

Authors:  Carmelo Nucera; Matthew A Nehs; Michal Mekel; Xuefeng Zhang; Richard Hodin; Jack Lawler; Vânia Nose; Sareh Parangi
Journal:  Thyroid       Date:  2009-10       Impact factor: 6.568

6.  Inhibition of tumor angiogenesis by the matrix metalloproteinase-activated anthrax lethal toxin in an orthotopic model of anaplastic thyroid carcinoma.

Authors:  Randall W Alfano; Stephen H Leppla; Shihui Liu; Thomas H Bugge; Janelle M Ortiz; Terry C Lairmore; Nicholas S Duesbery; Ian C Mitchell; Fiemu Nwariaku; Arthur E Frankel
Journal:  Mol Cancer Ther       Date:  2010-01-06       Impact factor: 6.261

Review 7.  Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.

Authors:  Robert C Smallridge; Laura A Marlow; John A Copland
Journal:  Endocr Relat Cancer       Date:  2008-11-05       Impact factor: 5.678

8.  Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer.

Authors:  Jennifer M Johnson; Stephen Y Lai; Paolo Cotzia; David Cognetti; Adam Luginbuhl; Edmund A Pribitkin; Tingting Zhan; Mehri Mollaee; Marina Domingo-Vidal; Yunyun Chen; Barbara Campling; Voichita Bar-Ad; Ruth Birbe; Madalina Tuluc; Ubaldo Martinez Outschoorn; Joseph Curry
Journal:  Semin Oncol       Date:  2015-09-24       Impact factor: 4.929

9.  Animal models of cancer in the head and neck region.

Authors:  Seungwon Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-06-27       Impact factor: 3.372

10.  Cell surface and secreted protein profiles of human thyroid cancer cell lines reveal distinct glycoprotein patterns.

Authors:  Arthur Arcinas; Ten-Yang Yen; Electron Kebebew; Bruce A Macher
Journal:  J Proteome Res       Date:  2009-08       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.